25.23
0.08%
-0.02
시간 외 거래:
25.23
Royalty Pharma Plc (RPRX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
4.71%
567.98
|
596.07 | 536.31 | 538.20 | 683.97 |
Operating Expenses
|
3,914%
641.75
|
-16.83 | 384.87 | 289.36 | 205.00 |
Interest Income/Expense |
6.40%
44.23
|
47.26 | 46.03 | 46.95 | 46.95 |
Benefits Costs and Expenses |
570.92%
572.25
|
-121.52 | 414.24 | 186.87 | 174.88 |
Costs And Expenses |
3,914%
641.75
|
-16.83 | 384.87 | 289.36 | 205.00 |
Provision For Loan, Lease, And Other Losses |
107.34%
0.669
|
-9.12 | 29.91 | -5.922 | 7.415 |
Operating Income/Loss |
112.04%
-73.77
|
612.90 | 151.44 | 248.84 | 478.97 |
Nonoperating Income/Loss |
33.61%
69.50
|
104.69 | -29.36 | 102.50 | 30.12 |
Income/Loss Before Equity Method Investments |
98.62%
9.876
|
717.32 | 127.30 | 352.11 | 474.48 |
Income/Loss From Equity Method Investments |
5,379%
-14.15
|
0.268 | -5.222 | -0.77 | 34.61 |
Income/Loss From Continuing Operations Before Tax |
100.60%
-4.273
|
717.59 | 122.08 | 351.34 | 509.09 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
100.60%
-4.273
|
717.59 | 122.08 | 351.34 | 509.09 |
Net Income/Loss
|
100.60%
-4.273
|
717.59 | 122.08 | 351.34 | 509.09 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
104.05%
-9.051
|
223.25 | 49.96 | 123.71 | 168.33 |
Basic Average Shares |
80,068%
448.62
|
-0.561 | 448.44 | 450.40 | 445.61 |
Diluted Average Shares |
32,983%
597.48
|
-1.817 | 601.14 | 605.86 | 607.25 |
Basic Earnings Per Share |
99.10%
0.01
|
1.11 | 0.16 | 0.51 | 0.76 |
Diluted Earnings Per Share |
99.09%
0.01
|
1.10 | 0.16 | 0.50 | 0.76 |
Common Stock Dividends |
5.00%
0.21
|
0.20 | 0.20 | 0.20 | 0.20 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):